FedCircuitBlog

SCOTUS Denies Review of Patent Dispute over Groundbreaking Cancer Treatment – Blake Brittain wrote an article for Reuters explaining the Supreme Court’s decision to decline review in Ono Pharmaceutical Co Ltd v. Dana-Farber Cancer Institute Inc. 

Slow down on Mandamus: Federal Circuit Refuses to Short Circuit Judge Albright’s Decision Process – On PatentlyO.com, Dennis Crouch posted about another mandamus venue case arriving at the Federal Circuit from Judge Albright’s Waco, Texas courtroom. 

Here’s the latest.

Here is an update on recent activity at the Supreme Court in cases decided by the Federal Circuit. Five new petitions were filed with the Court–four in patent cases and one in a pro se case. Additionally, the respondents in two different patent cases filed their briefs in opposition, while the Court requested a response to a petition in a government contract case. Upon the parties’ request, the Court dismissed Ariosa Diagnostics, Inc. v. Illumina Inc.. Finally, the Court denied two other petitions, one in a trademark case and one in a patent case.

Here are the details.

Here is an update on recent activity at the Supreme Court in cases decided by the Federal Circuit.

• The Court invited the Acting Solicitor General to file a brief in American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, a patent case presenting questions related to eligibility.
• Five new petitions were filed in patent, veterans, Tucker Act, and trademark cases.
• Seventeen new briefs in opposition were filed in sixteen cases.
• Five new reply briefs were filed.
• One supplemental brief was filed.
• One amicus brief was filed in a patent case.
• Five waivers of right to respond were submitted.
• The Court denied eight petitions.

Here are the details.

Here is an update on recent activity at the Supreme Court in cases decided by the Federal Circuit.

• The Court received four new petitions for writ of certiorari.
• One new amicus brief was filed with the Court in Sandoz Inc. v. Immunex Corp. by The Association for Accessible Medicines and America’s Health Insurance Plans, Inc.
• One new waiver of right to respond was filed with the Court by the Secretary of Veterans Affairs in Jones v. Secretary of Veterans Affairs.

Here are the details.

Here is an update on recent en banc activity at the Federal Circuit. In one of the two pending en banc veterans cases, the Court invited the National Organization of Veterans Advocates to file an amended petition. In the other case, two amicus briefs were filed. With respect to petitions for en banc rehearing in patent cases, highlights include a new invitation to respond to a petition raising questions related to literal infringement and claim construction; a new amicus brief filed in a case raising questions related to prosecution history estoppel, vitiation, and reasonable royalties; and the denial of two petitions in cases raising questions related to patent marking, expert testimony, willful infringement, and inventorship. Here are the details.

• Full Federal Circuit Won’t Revisit Dana-Farber Win on Named Inventors – The Federal Circuit refused to rehear a case en banc involving the addition of inventors to a pharmaceutical patent.
• CAFC Affirms District Court Dismissal of Declaratory Judgment Under Doctrine of ‘Abstention’ – The Doctrine of ‘Abstention’ guided the Federal Circuit’s decision in Warsaw Orthopedic, Inc. v. Sasso to affirm the lower court’s ruling to dismiss a claim for declaratory judgment.
• Broadest Reasonable Interpretation in Light of the Specification – Snyders Heart Valve can continue its infringement claims against St. Jude’s Medical after a recent decision by the Federal Circuit.

Here’s the latest.

Here is an update on recent en banc activity at the Federal Circuit. In one of the two cases in which the court has granted en banc hearings, the National Organization of Veterans Advocates filed a reply brief. In cases with pending petitions for en banc consideration, highlights include responses to two petitions raising issues related to patent eligibility and inventorship, and a voluntary withdrawal of a petition related to venue.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include a new petition raising a question related to claim construction; new invitations to respond to petitions raising questions related to novelty and non-obviousness; and the denial of two petitions raising questions related to design patent law and joinder in inter partes review proceedings. Here are the details.

Here is an update on recent en banc activity at the Federal Circuit. Highlights include new petitions filed in four patent cases raising questions related to remedies, transfer of venue, novelty, non-obviousness, and real-party-in-interest rules, as well as a response to a petition raising questions related to double-patenting. Here are the details.

• GI Bill Ruling Won’t Come in Time for Fall Classes – Veteran students deprived of GI Bill benefits needed for the Fall semester while waiting for Federal Circuit input.
• Prior Work Can Lead to Joint Inventorship – Work by co-inventors performed independently and publicly disclosed prior to the conception of the claimed invention can constitute joint inventorship.
• Federal Circuit Won’t Revisit Relistor Ruling – Valeant failed to persuade the Federal Circuit to revisit their obviousness decision in Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc.

Here’s the latest.